| Literature DB >> 36091225 |
Haiquan Xu1, Yanzhi Guo1, Shaolun Cai1, Xiuli Wang1, Junling Qu1, Yunqian Ma1, Hongyun Fang2, Junmao Sun1.
Abstract
Steamed potato bread has received much attention from nutritionists and agriculturalists since it became a staple food of China in 2015. Epidemiological studies have indicated that potatoes may cause diabetes and hypertension, but few trials have evaluated this effect. Through a clinical trial, we evaluated the effect of steamed potato bread intake on adults. In total, 49 and 30 individuals were assigned to the intervention and control groups, respectively. Potato-wheat bread (raw wheat flour and cooked potato flour in the ratio 3:7) and steamed wheat bread (100% raw wheat flour) were provided to the intervention and control groups, respectively, once a day for 4 weeks. Compared with the control group, the intervention group showed significant net changes in weight (-0.6 kg; 95% confidence interval [CI]: -1.2, -0.1; p = 0.016), body mass index (BMI, -0.2 kg/m2; 95% CI: -0.4, -0.1; p = 0.020), low-density lipoprotein cholesterol (LDL-c, -0.22 mmol/L; 95% CI: -0.49, -0.01; p = 0.035), and the urinary level of Na+/K+ (-2.4; 95% CI: -4.1, -0.7; p = 0.007). In conclusion, the steamed potato-wheat bread intake for 4 weeks resulted in decreases in weight, BMI, LDL-c, and the urinary Na+/K+ level among Chinese adults.Entities:
Keywords: BMI; glucose; lipids; potato bread; potato staple food; urinary Na+/K+
Year: 2022 PMID: 36091225 PMCID: PMC9453233 DOI: 10.3389/fnut.2022.987285
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1CONSORT flowchart of the study.
Characteristics of participants at baseline.
|
|
|
|
|---|---|---|
| Total ( | 30 | 49 |
| Male | 14 (46.7) | 14 (28.6) |
| Female | 16 (53.3) | 35 (71.4) |
| Han people | 26 (86.7) | 46 (93.9) |
| Minority | 4 (13.3) | 3 (6.1) |
| Age [year, Mean (SD)] | 41.0 (8.6) | 42.8 (8.2) |
| Height [cm, Mean (SD)] | 165.7 (8.4) | 163.1 (6.5) |
| Weight [kg, Mean (SD)] | 64.7 (12.5) | 62.9 (11.4) |
| BMI [kg/m2, Mean (SD)] | 23.4 (3.0) | 23.5 (3.3) |
| Bread intake [g/day | 113.8 (50.3) | 136.9 (34.9) |
| Mean (SD)] |
p <0.05.
Comparison based on chi-square test.
Comparison based on t-test. BMI, body mass index.
Nutrients provided by the daily steamed breads (mean ± SD).
|
|
|
|
|
|---|---|---|---|
| Energy (kcal) | 278.4 ± 123.1 | 301.2 ± 76.9 | 0.313 |
| Protein (g) | 9.5 ± 4.2 | 8.7 ± 2.2 | 0.355 |
| Fat (g) | 1.9 ± 0.8 | 1.7 ± 0.4 | 0.217 |
| Carbohydrate (g) | 54.6 ± 24.1 | 61.1 ± 15.6 | 0.194 |
| Fiber (g) | 0.6 ± 0.3 | 1.2 ± 0.3 | <0.001 |
| Vitamin E (mg) | 0.80 ± 0.35 | 1.24 ± 0.32 | <0.001 |
| Vitamin B1 (mg) | 0.08 ± 0.04 | 0.12 ± 0.03 | <0.001 |
| Vitamin B2 (mg) | 0.02 ± 0.01 | 0.07 ± 0.02 | <0.001 |
| Sodium (mg) | 223.76 ± 98.96 | 14.04 ± 3.58 | <0.001 |
| Potassium (mg) | 148.94 ± 65.87 | 429.03 ± 109.47 | <0.001 |
| Calcium (mg) | 16.81 ± 7.44 | 19.76 ± 5.04 | 0.062 |
| Iron (mg) | 1.13 ± 0.50 | 1.19 ± 0.30 | 0.582 |
| Zinc (mg) | 0.47 ± 0.21 | 0.64 ± 0.16 | 0.133 |
The t-test was used for the comparison between groups.
Outcomes of the intervention for groups and subgroups.
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Overall | Weight (kg) | 64.7 ± 12.5 | 65.2 ± 12.7** | 62.9 ± 11.4 | 62.6 ± 11 | −0.6 (−1.2, −0.1) | 0.016 |
| BMI (kg/m2) | 23.4 ± 3.1 | 23.5 ± 3.1** | 23.5 ± 3.3 | 23.4 ± 3.1 | −0.2 (−0.4, −0.1) | 0.020 | |
| SBP (mmHg) | 121.6 ± 13.8 | 120.2 ± 14.9 | 121.2 ± 15.9 | 120 ± 16.3 | 0.1 (−4.9, 5.1) | 0.967 | |
| DBP (mmHg) | 75.1 ± 11.1 | 70.3 ± 9.3** | 72.3 ± 11.2 | 70.2 ± 10.8 | 2.8 (−0.6, 6.2) | 0.100 | |
| GLU (mmol/L) | 5.29 ± 0.58 | 5.37 ± 0.55 | 5.10 ± 0.47 | 5.12 ± 0.50 | −0.01 (−0.39, 0.07) | 0.900 | |
| INS (mIU/L) | 11.19 ± 3.17 | 13.17 ± 3.81** | 9.91 ± 6.18 | 12.94 ± 6.12** | 1.22 (−0.49, 2.93) | 0.158 | |
| CHO (mmol/L) | 4.8 ± 0.82 | 4.86 ± 0.89 | 4.71 ± 0.78 | 4.58 ± 0.80 | −0.17 (−0.43, 0.09) | 0.194 | |
| TG (mmol/L) | 1.29 ± 1.02 | 1.62 ± 2.33 | 1.07 ± 0.47 | 1.16 ± 0.54 | −0.22 (−0.80, 0.35) | 0.440 | |
| LDL-c (mmol/L) | 3.08 ± 0.87 | 3.15 ± 0.87 | 2.86 ± 0.8 | 2.67 ± 0.78** | −0.22 (−0.49, −0.01) | 0.035 | |
| HDL-c (mmol/L) | 1.44 ± 0.28 | 1.47 ± 0.34 | 1.61 ± 0.36 | 1.58 ± 0.37 | −0.24 (−0.77, 0.29) | 0.371 | |
| Urinary Na+ (mmol/L) | 129.4 ± 34.5 | 141.5 ± 43.4 | 134.3 ± 39.5 | 138.8 ± 35.7 | −7.1 (−29.1, 14.9) | 0.520 | |
| Urinary K+ (mmol/L) | 39.7 ± 27.0 | 48.0 ± 33.5 | 31.5 ± 20.4 | 54.1 ± 35.5** | 14.4 (−4.7, 33.5) | 0.136 | |
| Urinary Na+/K+ | 4.7 ± 2.8 | 4.3 ± 2.5 | 6.0 ± 3.6 | 3.3 ± 1.7** | −2.4 (−4.1, −0.7) | 0.007 | |
| Male | Weight (kg) | 74.5 ± 8.6 | 75.1 ± 8.7* | 73.3 ± 11.8 | 73.0 ± 11.1 | −0.7 (−1.9, 0.4) | 0.178 |
| BMI (kg/m2) | 25 ± 2.4 | 25.2 ± 2.4* | 25.6 ± 3.5 | 25.5 ± 3.3 | −0.3 (−0.6, 0.1) | 0.093 | |
| SBP (mmHg) | 126.1 ± 12.5 | 124.8 ± 13.4 | 124.3 ± 17.1 | 125.2 ± 12.2 | 2.2 (−4.9, 9.3) | 0.532 | |
| DBP (mmHg) | 79.9 ± 10.5 | 73.7 ± 9.5** | 74.5 ± 11.9 | 73.5 ± 10.2 | 5.3 (0.4, 10.1) | 0.034 | |
| GLU (mmol/L) | 5.38 ± 0.38 | 5.44 ± 0.4 | 5.49 ± 0.39 | 5.5 ± 0.54 | 0.06 (−0.28, 0.40) | 0.727 | |
| INS (mIU/L) | 11.57 ± 2.52 | 13.85 ± 3** | 12.5 ± 8.71 | 16.49 ± 8.94* | 1.72 (−2.29, 5.73) | 0.386 | |
| CHO (mmol/L) | 4.88 ± 0.74 | 4.84 ± 0.78 | 4.82 ± 0.92 | 4.7 ± 0.85 | 0.01 (−0.42, 0.44) | 0.955 | |
| TG (mmol/L) | 1.46 ± 1.14 | 1.38 ± 0.74 | 1.27 ± 0.61 | 1.34 ± 0.71 | 0.18 (−0.42, 0.77) | 0.545 | |
| LDL-c (mmol/L) | 3.19 ± 0.78 | 3.22 ± 0.89 | 3.07 ± 0.97 | 2.87 ± 0.84 | −0.14 (−0.65, 0.36) | 0.567 | |
| HDL-c (mmol/L) | 1.39 ± 0.34 | 1.38 ± 0.32 | 1.44 ± 0.3 | 1.45 ± 0.25 | 0.02 (−0.13, 0.17) | 0.778 | |
| Urinary Na+ (mmol/L) | 135.3 ± 31.1 | 136.3 ± 44.7 | 140.8 ± 44.5 | 140.6 ± 44.5 | −1.2 (−43.6, 41.2) | 0.954 | |
| Urinary K+ (mmol/L) | 48.5 ± 30.3 | 44.9 ± 37.1 | 31.8 ± 19.5 | 42.6 ± 19.6 | 14.4 (−17.6, 46.5) | 0.364 | |
| Urinary Na+/K+ | 3.9 ± 2.4 | 4.6 ± 2.6 | 5.9 ± 3.1 | 3.8 ± 1.8** | −2.9 (−5.6, −0.1) | 0.039 | |
| Female | Weight (kg) | 56.1 ± 8.3 | 56.5 ± 8.5 | 58.7 ± 8.2 | 58.4 ± 7.8 | −0.5 (−1.1, 0) | 0.072 |
| BMI (kg/m2) | 22 ± 2.9 | 22.1 ± 2.9 | 22.7 ± 2.9 | 22.6 ± 2.7 | −0.3 (−0.6, 0) | 0.048 | |
| SBP (mmHg) | 117.6 ± 14.1 | 116.2 ± 15.3 | 120 ± 15.5 | 117.9 ± 17.4 | −0.7 (−7.9, 6.5) | 0.851 | |
| DBP (mmHg) | 70.9 ± 10.1 | 67.3 ± 8.4* | 71.4 ± 11 | 68.9 ± 11 | 1.2 (−3.6, 6.0) | 0.624 | |
| GLU (mmol/L) | 5.22 ± 0.71 | 5.3 ± 0.66 | 4.94 ± 0.41 | 4.97 ± 0.39 | −0.05 (−0.28, 0.19) | 0.689 | |
| INS (mIU/L) | 10.86 ± 3.7 | 12.57 ± 4.41** | 8.88 ± 4.58 | 11.52 ± 3.87** | 0.99 (−0.44, 2.41) | 0.171 | |
| CHO (mmol/L) | 4.74 ± 0.91 | 4.89 ± 0.99 | 4.66 ± 0.72 | 4.53 ± 0.78 | −0.29 (−0.63, 0.05) | 0.097 | |
| TG (mmol/L) | 1.15 ± 0.92 | 1.83 ± 3.15 | 0.99 ± 0.38 | 1.08 ± 0.44 | −0.58 (−1.44, 0.29) | 0.184 | |
| LDL-c (mmol/L) | 2.98 ± 0.96 | 3.09 ± 0.88 | 2.78 ± 0.72 | 2.59 ± 0.75* | −0.28 (−0.55, −0.01) | 0.049 | |
| HDL-c (mmol/L) | 1.49 ± 0.21 | 1.54 ± 0.34 | 1.68 ± 0.36 | 1.64 ± 0.4 | −0.10 (−0.25, 0.05) | 0.176 | |
| Urinary Na+ (mmol/L) | 123.9 ± 37.6 | 146.4 ± 43.1 | 131.5 ± 37.6 | 137.9 ± 31.7 | −14.7 (−41, 11.6) | 0.265 | |
| Urinary K+ (mmol/L) | 31.5 ± 21.3 | 50.9 ± 30.8* | 31.5 ± 21.1 | 59.4 ± 40.0** | 8.9 (−15.7, 33.5) | 0.470 | |
| Urinary Na+/K+ | 5.4 ± 3.0 | 4.2 ± 2.5 | 6.0 ± 3.8 | 3.1 ± 1.6** | −1.7 (−4.0, 0.7) | 0.162 | |
The linear mixed effects model was used for comparing the groups. The comparison of overall participants was adjusted for sex, energy intake and physical activity. The paired t-test was used for within-group comparison; .
Figure 2Significant intervention effects (β) in the two groups: (A) weight, (B) body mass index, (C) low-density lipoprotein cholesterol, and (D) urinary Na+/K+.